![]() |
市場調查報告書
商品編碼
1904603
寵物微生物組營養市場預測至2032年:全球產品、寵物類型、劑型、成分、通路、健康用途和區域分析Pet Microbiome Based Nutrition Market Forecasts to 2032 - Global Analysis By Product, Pet Type, Form, Ingredient Source, Distribution Channel, Health Application and By Geography |
||||||
根據 Stratistics MRC 的一項研究,全球寵物微生物組營養市場預計到 2025 年價值 12.2 億美元,預計到 2032 年將達到 22 億美元,在預測期內複合年成長率為 8.7%。
寵物微生物組營養是指一種以科學為基礎的寵物健康方法,它根據動物腸道微生物組的組成和活性來配製膳食、補充劑和功能性成分。這種方法植根於傳統營養學,並融合了現代微生物學和基因組學,專注於平衡有益菌群,以支持消化功能、免疫力、新陳代謝和整體健康。透過分析微生物多樣性和代謝反應,可以針對每隻寵物量身定做營養干預措施。隨著研究的不斷深入,微生物組營養正在重塑預防性獸醫護理,將檢驗的餵食原則與前瞻性的精準醫療策略相結合,造福伴侶動物。
寵物人性化程度提高與健康意識增強
寵物人性化以及人們日益增強的健康意識正在推動對基於微生物組的營養解決方案的強勁需求。寵物不再只是被視為動物,而是家庭成員,這促使飼主尋求預防性和科學支持的營養方案。人們對腸道健康在免疫力、消化和壽命方面的重要作用的認知顯著提高。以微生物組為中心的飲食和補充劑提供了一種積極主動的健康維護方法,而非疾病治療,這與現代寵物護理理念完美契合,並推動了全球市場的成長。
保健品高成本
微生物組補充劑和特製寵物食品的高成本仍然是一大障礙。先進的配方工藝、高品質的菌株以及臨床檢驗都會增加生產成本,而這些成本最終會轉嫁給消費者。尤其是在發展中地區,消費者對價格的高度敏感限制了其廣泛應用,儘管人們的認知度正在不斷提高。高昂的價格也阻礙了消費者重複購買和長期使用。在實現規模經濟和建立成本效益高的生產方法之前,價格因素很可能仍是市場滲透的一大障礙。
微生物組科學進展
微生物組科學的持續進步為市場拓展提供了巨大的機會。微生物定序、菌株鑑定和功能圖譜繪製的突破,使得高度標靶的營養配方成為可能。對腸-腦和腸-免疫連結的深入理解,正將應用範圍從消化擴展到行為、免疫和代謝健康領域。隨著研究的深入和配方精準度的提高,企業可以開發差異化的個人化營養解決方案,從而在寵物預防和治療護理領域開闢新的成長途徑。
監管挑戰
監管挑戰對市場構成潛在威脅。益生菌、功能性成分和健康聲明的區域監管不一致,使產品核可和商業化變得複雜。對標籤、功效檢驗和安全標準的嚴格審查增加了合規成本。此外,食品和治療產品之間界限不清也可能延遲產品上市。成功應對這些不斷變化的法規結構至關重要,違規可能會限制產品供應並阻礙創新。
新冠疫情對寵物微生物組營養市場產生了整體正面影響。疫情封鎖期間寵物飼養量的激增帶動了對高階營養和健康促進產品的需求。人們對免疫力和預防保健的日益關注也推動了寵物腸道健康解決方案的發展。儘管供應鏈中斷暫時影響了生產,但電子商務的加速發展和直銷模式的強化增強了市場的韌性,為疫情後的持續成長提供了支撐。
預計在預測期內,消化健康領域將佔據最大的市場佔有率。
由於消化系統健康在寵物整體健康中扮演著核心角色,預計在預測期內,該細分市場將佔據最大的市場佔有率。消化器官系統問題是伴侶動物最常見的健康問題之一,因此,針對腸道健康的營養解決方案的需求持續成長。以微生物組為基礎的產品已顯著改善了消化功能、糞便品質和營養吸收,增強了消費者的信心。強大的科學基礎和快速見效的效果,使得消化系統健康成為推廣以微生物組為基礎的寵物營養產品的基石。
預計在預測期內,細菌菌株細分市場將呈現最高的複合年成長率。
由於對菌株特異性功效的需求不斷成長,預計在預測期內,細菌菌株細分市場將呈現最高的成長率。微生物組研究的進展使得人們能夠識別與免疫、消化和代謝平衡相關的特定細菌菌株。寵物飼主和獸醫越來越傾向於選擇經過臨床檢驗的精準配方產品。個人化和依證營養管理的日益重要性推動了專有細菌菌株的創新,使該細分市場成為未來市場擴張的關鍵驅動力。
由於寵物擁有率的快速成長、都市生活方式的普及以及可支配收入的增加,亞太地區預計將在預測期內佔據最大的市場佔有率。人們對寵物營養意識提升、獸醫服務的擴展以及高階寵物食品的日益普及,都支撐了強勁的需求。中國、日本和澳洲等國家正在推動對功能性和預防性寵物營養的需求,使該地區主導。
在預測期內,北美地區預計將實現最高的複合年成長率,這主要得益於其先進的寵物醫療保健基礎設施和消費者較高的健康意識。該地區的寵物飼主正積極投資以科學為基礎的優質營養產品和預防性健康解決方案。主要企業的強大實力、研發的持續進步以及直銷模式的普及,都進一步推動了這項成長。該地區對創新的開放態度,使得基於微生物組的營養療法成為傳統寵物護理方法的自然演進。
According to Stratistics MRC, the Global Pet Microbiome Based Nutrition Market is accounted for $1.22 billion in 2025 and is expected to reach $2.20 billion by 2032 growing at a CAGR of 8.7% during the forecast period. Pet Microbiome Based Nutrition refers to a science-driven approach to pet health that formulates diets, supplements, and functional ingredients based on the composition and activity of an animal's gut microbiome. Rooted in classical nutrition and strengthened by modern microbiology and genomics, it focuses on balancing beneficial bacteria to support digestion, immunity, metabolism, and overall wellness. By analyzing microbial diversity and metabolic responses, this approach enables targeted nutritional interventions tailored to individual pets. As research advances, microbiome-based nutrition is reshaping preventive veterinary care, blending time-tested feeding principles with forward-looking, precision health strategies for companion animals.
Rising Pet Humanization & Health Awareness
Rising pet humanization and growing health awareness are driving strong demand for microbiome-based nutrition solutions. Pets are no longer viewed merely as animals but as integral family members, encouraging owners to seek preventive, science-backed nutrition. Awareness of gut health's role in immunity, digestion, and longevity has expanded significantly. Microbiome-focused diets and supplements offer a proactive way to maintain wellness rather than treat illness, aligning perfectly with modern pet care philosophies and accelerating market growth worldwide.
High Cost of Supplements
High costs associated with microbiome-based supplements and specialized pet foods remain a key restraint. Advanced formulation processes, high-quality bacterial strains, and clinical validation increase production expenses, which are passed on to consumers. Price sensitivity, particularly in developing regions, limits widespread adoption despite rising awareness. Premium pricing also restricts repeat purchases and long-term usage. Until economies of scale and cost-efficient production methods mature, affordability will continue to challenge broader market penetration.
Advances in Microbiome Science
Ongoing advances in microbiome science present a major opportunity for market expansion. Breakthroughs in microbial sequencing, strain identification, and functional mapping are enabling highly targeted nutritional formulations. Improved understanding of gut-brain and gut-immune connections is expanding applications beyond digestion to behavior, immunity, and metabolic health. As research deepens and formulation precision improves, companies can develop differentiated, personalized nutrition solutions, opening new growth avenues across preventive and therapeutic pet care segments.
Regulatory Challenges
Regulatory challenges pose a potential threat to the market. Inconsistent regulations governing probiotics, functional ingredients, and health claims across regions complicate product approvals and commercialization. Stricter scrutiny on labeling, efficacy validation, and safety standards increases compliance costs. Additionally, unclear classification between food and therapeutic products can delay market entry. Navigating these evolving regulatory frameworks is essential, as failure to comply may restrict product availability and slow innovation.
The COVID-19 pandemic had a net positive impact on the pet microbiome-based nutrition market. A surge in pet adoption during lockdowns increased demand for premium nutrition and wellness products. Heightened focus on immunity and preventive health extended to pets, boosting interest in gut health solutions. While supply chain disruptions affected production temporarily, accelerated e-commerce adoption and direct-to-consumer models strengthened market resilience, supporting sustained post-pandemic growth.
The digestive health segment is expected to be the largest during the forecast period
The digestive health segment is expected to account for the largest market share during the forecast period, due to its central role in overall pet wellness. Digestive issues are among the most common health concerns in companion animals, driving consistent demand for gut-focused nutritional solutions. Microbiome-based products deliver visible improvements in digestion, stool quality, and nutrient absorption, strengthening consumer trust. Strong scientific backing and immediate benefits make digestive health the cornerstone of microbiome-based pet nutrition adoption.
The bacterial strains segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the bacterial strains segment is predicted to witness the highest growth rate, due to rising demand for strain-specific efficacy. Advances in microbiome research have enabled identification of targeted bacterial strains linked to immunity, digestion, and metabolic balance. Pet owners and veterinarians increasingly prefer clinically validated, precision-formulated products. As personalization and evidence-based nutrition gain importance, innovation in proprietary bacterial strains is accelerating, positioning this segment as a key driver of future market expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid growth in pet ownership, urban lifestyles, and rising disposable incomes. Increasing awareness of pet nutrition, expanding veterinary services, and growing availability of premium pet food products support strong adoption. Countries such as China, Japan, and Australia are witnessing heightened demand for functional and preventive pet nutrition, making the region a dominant force in the global microbiome-based nutrition market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced pet healthcare infrastructure and high consumer awareness. Pet owners in the region actively invest in premium, science-backed nutrition and preventive wellness solutions. Strong presence of key players, continuous research advancements, and widespread adoption of direct-to-consumer models further accelerate growth. The region's openness to innovation positions microbiome-based nutrition as a natural evolution of traditional pet care practices.
Key players in the market
Some of the key players in Pet Microbiome Based Nutrition Market include Nestle Purina PetCare, NOW Health Group, Mars Petcare, NaturVet, Hill's Pet Nutrition, Ark Naturals Company, Nutramax Laboratories, PetAg, Inc., Zesty Paws, Fera Pets, VetriScience Laboratories, AnimalBiome, Chr. Hansen Holding A/S, ADM and Novozymes A/S.
In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.